INKON Life Technology Co Ltd (300143.SZ) stock: key figures, P/E, revenue and dividend

Consumer Staples · Packaged Foods & Meats · China · ISIN CNE100000XF6

Price
7.45 CNY
Market cap
7.25 bn CNY
P/E (2025)
105.90
P/S (2025)
3.84
Dividend yield
0.34 %
Net margin
3.64 %
Return on equity (ROE)
2.62 %
Return on assets (ROA)
1.63 %

INKON Life Technology Co Ltd financials

Fiscal year20242025
Revenue1.56 bn CNY1.89 bn CNY
Gross profit403.28 m CNY510.93 m CNY
Operating income157.17 m CNY231.36 m CNY
EBIT161.20 m CNY171.30 m CNY
Net income115.42 m CNY68.54 m CNY
Diluted EPS – continuing operations0.15 CNY0.09 CNY

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About INKON Life Technology Co Ltd

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Qingdao, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.